Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Fulcrum Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues25.218.5
            Revenue growth36.2% 
Cost of goods sold33.523.0
Gross profit-8.3-4.5
            Gross margin-33.0%-24.3%
General and administrative8.34.5
EBIT-33.5-23.0
            EBIT margin-133.0%-124.3%
Pre-tax income-39.1-25.4
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-39.1-25.4
            Net margin-155.4%-137.2%
 
Diluted EPS($31.14)($35.68)
Shares outstanding (diluted)1.30.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy